Gliclazide and Differential white blood cell count abnormal - a phase IV clinical study of FDA data

Summary:

Differential white blood cell count abnormal is reported as a side effect among people who take Gliclazide (gliclazide), especially for people who are male, 40-49 old, have been taking the drug for 1 - 2 years also take Clozaril, and have Depression.

The phase IV clinical study analyzes which people have Differential white blood cell count abnormal when taking Gliclazide. It is created by eHealthMe based on reports of 27,903 people who have side effects when taking Gliclazide from the FDA, and is updated regularly.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

What is Differential white blood cell count abnormal?

Differential white blood cell count abnormal is found to be associated with 89 drugs and 290 conditions by eHealthMe. Check the latest studies of Differential white blood cell count abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

27,903 people reported to have side effects when taking Gliclazide.
Among them, 25 people (0.09%) have Differential white blood cell count abnormal.

Could Gliclazide cause Differential white blood cell count abnormal?

Among these 25 people:

How long have people been on Gliclazide when they have Differential white blood cell count abnormal? *

What is the gender of people who have Differential white blood cell count abnormal when taking Gliclazide? *

female: 26.09 %
male: 73.91 %

What is the age of people who have Differential white blood cell count abnormal when taking Gliclazide? *

What are other drugs people take besides Gliclazide? *

Clozaril: 25 people, 100.00%
Zopiclone: 14 people, 56.00%
Metformin: 9 people, 36.00%
Simvastatin: 3 people, 12.00%
Aspirin: 3 people, 12.00%
Sertraline: 2 people, 8.00%
Citalopram Hydrobromide: 2 people, 8.00%
Fish Oil: 1 person, 4.00%
Crestor: 1 person, 4.00%
Depakote: 1 person, 4.00%

What are other side effects people have besides Differential white blood cell count abnormal? *

Mean Cell Haemoglobin Increased (more than normal haemoglobin per red blood cell in a sample of blood): 13 people, 52.00%
Eosinophil Count Increased: 11 people, 44.00%
Mean Cell Haemoglobin Concentration Increased (more concentration of haemoglobin in a given volume of packed red blood cells): 10 people, 40.00%
Hepatic Steatosis (fatty liver disease): 6 people, 24.00%
Eosinophilia (eosinophil count in the peripheral blood exceeds): 5 people, 20.00%
Gamma-Glutamyltransferase Increased: 5 people, 20.00%
White Blood Cell Count Increased: 4 people, 16.00%
Thrombocytopenia (decrease of platelets in blood): 4 people, 16.00%
Mean Cell Volume Increased (more than normal average red blood cell volume): 4 people, 16.00%
Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 4 people, 16.00%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 16 people, 64.00%
Psychotic Disorder: 16 people, 64.00%
Depression: 16 people, 64.00%
Salivary Hypersecretion (excess saliva secretion): 15 people, 60.00%
Insomnia (sleeplessness): 14 people, 56.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 12.00%
Schizophrenia, Paranoid Type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect): 2 people, 8.00%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 2 people, 8.00%
Pain: 2 people, 8.00%
Weight Increased: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Gliclazide and have Differential white blood cell count abnormal?

- Check whether Differential white blood cell count abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gliclazide:

Gliclazide (28,131 reports)

Differential white blood cell count abnormal treatments and more:

Differential white blood cell count abnormal (2,986 reports)

How severe was Differential white blood cell count abnormal and when was it recovered:

Differential white blood cell count abnormal in Gliclazide

Expand to all the drugs that have ingredients of gliclazide:

Differential white blood cell count abnormal and drugs with ingredients of gliclazide

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gliclazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Differential white blood cell count abnormal:

Differential white blood cell count abnormal (89 drugs)

Browse all the conditions that are associated with Differential white blood cell count abnormal:

Differential white blood cell count abnormal (290 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gliclazide (the active ingredients of Gliclazide) and Gliclazide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.